Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 543,484 | 231,731 | 118,366 | 108,075 | 92,360 |
| Marketable Securities | 82,808 | 240,114 | 241,807 | 316,383 | 389,829 |
| TOTAL | $637,781 | $479,116 | $369,884 | $431,593 | $489,968 |
| Non-Current Assets | |||||
| PPE Net | 109,923 | 105,232 | 100,746 | 101,154 | 102,757 |
| Investments And Advances | 0 | 0 | 0 | 0 | 27,701 |
| Other Non-Current Assets | 77,063 | 79,634 | 75,294 | 78,131 | 80,825 |
| TOTAL | $186,986 | $184,866 | $176,040 | $179,285 | $211,283 |
| Total Assets | $824,767 | $663,982 | $545,924 | $610,878 | $701,251 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 31,572 | 26,603 | 24,255 | 20,009 | 20,454 |
| Accrued Expenses | 43,088 | 52,295 | 47,819 | 37,700 | 48,911 |
| TOTAL | $87,274 | $91,485 | $79,245 | $64,192 | $77,075 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Other Non-Current Liabilities | 69,612 | 71,859 | 71,943 | 72,996 | 71,184 |
| TOTAL | $70,612 | $72,859 | $72,943 | $73,996 | $72,184 |
| Total Liabilities | $157,886 | $164,344 | $152,188 | $138,188 | $149,259 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 224,449 | 224,239 | 157,841 | 157,801 | 157,168 |
| Common Shares | 9 | 8 | 7 | 7 | 7 |
| Retained earnings | -1,675,708 | -1,568,338 | -1,463,019 | -1,363,401 | -1,264,052 |
| Other shareholders' equity | -126 | -902 | -2,038 | -2,697 | -2,343 |
| TOTAL | $666,881 | $499,638 | $393,736 | $472,690 | $551,992 |
| Total Liabilities And Equity | $824,767 | $663,982 | $545,924 | $610,878 | $701,251 |